Neonatal Brain Injury
Clinical symptoms HIE severity Mild Moderate Severe Level of consciousness Hyperalert Lethargy Coma Seizures − +/− + Tone Normal or increased Decreased or increased Decreased Tendon reflexes Increased Increased or…
Clinical symptoms HIE severity Mild Moderate Severe Level of consciousness Hyperalert Lethargy Coma Seizures − +/− + Tone Normal or increased Decreased or increased Decreased Tendon reflexes Increased Increased or…
html xmlns=”http://www.w3.org/1999/xhtml” xmlns:mml=”http://www.w3.org/1998/Math/MathML” xmlns:epub=”http://www.idpf.org/2007/ops”> Chapter 17 Deep brain stimulation for tardive disorders Bernardo Rodrigues and Kelvin L. Chou Introduction Deep brain stimulation (DBS) is a procedure in which electrical wires…
html xmlns=”http://www.w3.org/1999/xhtml” xmlns:mml=”http://www.w3.org/1998/Math/MathML” xmlns:epub=”http://www.idpf.org/2007/ops”> Chapter 16 Imaging in medication-induced parkinsonism Danna Jennings Introduction Drug-induced parkinsonism (DIP) represents one of the most prevailing diagnostic dilemmas in movement disorders clinics and is…
html xmlns=”http://www.w3.org/1999/xhtml” xmlns:mml=”http://www.w3.org/1998/Math/MathML” xmlns:epub=”http://www.idpf.org/2007/ops”> Chapter 14 Ataxia Marina Sanchez Abraham and Oscar S. Gershanik Introduction In this chapter we will review the different types of drugs that may cause cerebellar…
html xmlns=”http://www.w3.org/1999/xhtml” xmlns:mml=”http://www.w3.org/1998/Math/MathML” xmlns:epub=”http://www.idpf.org/2007/ops”> Chapter 13 Antidepressants and movement disorders Gilles Fénelon In a study performed in 18 countries from every continent, the 12-month prevalence estimate of major depressive episodes…
html xmlns=”http://www.w3.org/1999/xhtml” xmlns:mml=”http://www.w3.org/1998/Math/MathML” xmlns:epub=”http://www.idpf.org/2007/ops”> Chapter 12 VPA, lithium, amiodarone, and other non-DA Michael R. Silver and Stewart A. Factor Introduction Considering that the characteristic motor features of Parkinson’s disease (PD)…
Figure 11.1 Management of motor complications in Parkinson’s disease 1. Glutamate receptor antagonists Abnormalities in the thalamo- and cortico-striatal glutamatergic transmission have long been implicated in the pathogenesis of LIDs….
html xmlns=”http://www.w3.org/1999/xhtml” xmlns:mml=”http://www.w3.org/1998/Math/MathML” xmlns:epub=”http://www.idpf.org/2007/ops”> Chapter 10 Medication-induced tremors Peter A. LeWitt Tremor, a regular to-and-fro movement generated by the uniform repeated activations of lower motor units, is a characteristic manifestation…
html xmlns=”http://www.w3.org/1999/xhtml” xmlns:mml=”http://www.w3.org/1998/Math/MathML” xmlns:epub=”http://www.idpf.org/2007/ops”> Chapter 9 Restless legs syndrome Roongroj Bhidayasiri and Pattamon Panyakaew Restless legs syndrome (RLS), recently renamed Willis-Ekbom disease (WED), is a sensorimotor disorder with a primary…
html xmlns=”http://www.w3.org/1999/xhtml” xmlns:mml=”http://www.w3.org/1998/Math/MathML” xmlns:epub=”http://www.idpf.org/2007/ops”> Chapter 8 Atypical antipsychotics and movement disorders Rob M.A. de Bie Introduction The term atypical antipsychotics alludes to the existence of a class of drugs which…